Exogenous High‐Mobility Group Box 1 Inhibits Apoptosis and Promotes the Proliferation of Lewis Cells via RAGE / TLR 4‐Dependent Signal Pathways
Upregulated high‐mobility group box 1 ( HMGB 1) has been found in many diseases. Nevertheless, the function of HMGB 1 on modulating the proliferation of lung cancer cells (Lewis cells) and inhibiting apoptosis is poorly understood, as well as the involved intracellular signalling. In the present stu...
Gespeichert in:
Veröffentlicht in: | Scandinavian journal of immunology 2014-06, Vol.79 (6), p.386-394 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Upregulated high‐mobility group box 1 (
HMGB
1) has been found in many diseases. Nevertheless, the function of
HMGB
1 on modulating the proliferation of lung cancer cells (Lewis cells) and inhibiting apoptosis is poorly understood, as well as the involved intracellular signalling. In the present study, we firstly found the apoptosis of Lewis was increased following Hanks’ balanced salt solution (
HBSS
)‐induced starvation, while it was rescued after exogenous
HMGB
1 protein was added; furthermore, the receptor for advanced glycation end products (
RAGE
) and
T
oll‐like receptor (
TLR
4) could coordinately improve the proliferation of tumour cells
in vitro,
and
HMGB
1 could enhance the phosphorylation of
PI
3
K
/
A
kt and
E
rk1/2, inhibit the expression of pro‐apoptosis protein
B
ax and promote the expression of anti‐apoptosis protein
B
cl‐2. These findings clearly demonstrated that
HMGB
1–
RAGE
/
TLR
4‐
PI
3
K
‐
A
kt/
E
rk1/2 pathway contributed to the proliferation of Lewis. Moreover, our observations provide experimental and theoretical basis for clinical biological therapy for cancers; it also may be a new target for intervention and treatment of lung cancer. |
---|---|
ISSN: | 0300-9475 1365-3083 |
DOI: | 10.1111/sji.12174 |